InspireMD, Inc. - 8-K Filing
InspireMD amends warrant terms for Series J and K holders, lowering exercise price to $0.7674 and setting termination date tied to FDA approval of CGuard Prime. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $NSPR